Usual and unusual care: Existing practice control groups in randomized controlled trials of behavioral interventions

Psychosomatic Medicine

Volumn 73, Issue 4, 2011, Pages 323-335

  Freedland, Kenneth E ^a   Mohr, David C ^b   Davidson, Karina W ^c   Schwartz, Joseph E ^d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

Control groups; delivery of health care; evidence based medicine methods; placebos; randomized controlled trials as topic methods; research design

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; BEHAVIOR THERAPY; COMMUNITY CARE; CONSENSUS; HEALTH CARE DISPARITY; HEALTH SERVICE; HUMAN; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITATIVE ANALYSIS; TREATMENT OUTCOME;

BEHAVIOR THERAPY; BEHAVIORAL RESEARCH; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONTROL GROUPS; EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; STANDARD OF CARE;

EID: 79955822459     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e318218e1fb     Document Type: Article

References (134)

1. Rosenthal R. Experimenter effects in behavioral research. New York: Appleton-Century-Crofts; 1966.
2. Paul GL. Strategy of outcome research in psychotherapy. J Consult Psychol 1967;31:109-18.
3. Kazdin AE. Therapy analogues and clinical trials in psychotherapy research. In: Hersen M, Michelson L, Bellack AS, editors. Issues in Psychotherapy Research. New York: Plenum Press; 1984:227-50.
4. Lang P, Lazovik A. Experimental desensitization of phobia. J Abnorm Soc Psychol 1963;66:519-25.
5. Ayllon T, Azrin NH. The measurement and reinforcement of behavior of psychotics. J Exp Anal Behav 1965;8:357-83.
6. Bernstein DA, Paul GL. Some comments on therapy analogue research with small animal 'phobias'. J Behav Ther Exp Psychiatry 1971;2:225-37.
7. Tharp RG, Wetzel RJ. Behavior modification in the natural environment. New York: Academic Press; 1969.
8. Rachman S, Marks I, Hodgson R. The treatment of obsessive-compulsive neurotics by modelling and flooding in vivo. Behav Res Ther 1973;11: 463-71.
9. Hersen M, Michelson L, Bellack AS. Historical overview. In: Hersen M, Michelson L, Bellack AS, editors. Issues in psychotherapy research. New York: Plenum Press; 1984:33-250.
10. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry 1989;46:971-82. (Pubitemid 19278225)
11. Cook TD, Campbell DT. Quasi-experimentation: design and analysis issues for field settings. Boston: Houghton Mifflin; 1979.
12. Kazdin AE. Research design in clinical psychology. 4th ed. Boston: Allyn and Bacon; 2003.
13. Nock MK, Janis IB, Wedig MM. Research designs. In: Nezu AM, Nezu CM, editors. Evidence-based outcome research: a practical guide to conducting randomized controlled trials for psychosocial interventions. New York, NY: Oxford University Press; 2008:201-18.
14. Kendall PC, Holmbeck G, Verduin T. Methodology, design, and evaluation in psychotherapy research. In: Lambert MJ, editor. Bergin and Gar-field's handbook of psychotherapy and behavior change. 5th ed. New York, NY: Wiley; 2004:16-43.
15. Campbell DT, Stanley JC. Experimental and quasi-experimental designs for research. Chicago: R. McNally; 1966.
16. Mohr DC, Spring B, Freedland KE, Beckner V, Arean P, Hollon SD, Ockene J, Kaplan R. The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother Psychosom 2009;78:275-84.
17. Leon AC, Solomon DA. Toward rapproachment in the placebo control debate. A calculated compromise of power. Eval Health Prof 2003;26: 404-14. (Pubitemid 37373026)
18. Hochman M, McCormick D. Characteristics of published comparative effectiveness studies of medications. JAMA 2010;303:951-8.
19. Thompson BT, Schoenfeld D. Usual care as the control group in clinical trials of nonpharmacologic interventions. Proc Am Thorac Soc 2007;4: 577-82. (Pubitemid 47547855)
20. van der Graaf R, van Delden JJ. What is the best standard for the standard of care in clinical research? Am J Bioeth 2009;9:35-43.
21. Au DH, Castro M, Krishnan JA. Selection of controls in clinical trials: introduction and conference summary. Proc Am Thorac Soc 2007;4: 567-9. (Pubitemid 47547852)
22. Dawson L, Zarin DA, Emanuel EJ, Friedman LM, Chaudhari B, Goodman SN. Considering usual medical care in clinical trial design. PLoS Med 2009;6:e1000111.
23. Minneci PC, Eichacker PQ, Danner RL, Banks SM, Natanson C, Deans KJ. The importance of usual care control groups for safety monitoring and validity during critical care research. Intensive Care Med 2008;34:942-7.
24. Silverman HJ, Miller FG. Control group selection in critical care randomized controlled trials evaluating interventional strategies: an ethical assessment. Crit Care Med 2004;32:852-7. (Pubitemid 38340087)
25. Takala J. Better conduct of clinical trials: the control group in critical care trials. Crit Care Med 2009;37(suppl 1):S80-90.
26. Arean PA, Alvidrez J. Ethical considerations in psychotherapy effectiveness research: choosing the comparison group. Ethics Behav 2002;12: 63-73. (Pubitemid 36630400)
27. Brigham GS, Feaster DJ, Wakim PG, Dempsey CL. Choosing a control group in effectiveness trials of behavioral drug abuse treatments. J Subst Abuse Treat 2009;37:388-97.
28. Burns T. End of the road for treatment-as-usual studies? Br J Psychiatry 2009;195:5-6.
29. Degenholtz HB, Parker LS, Reynolds CF. Trial design and informed consent for a clinic-based study with a treatment as usual control arm. Ethics Behav 2002;12:43-62. (Pubitemid 36630399)
30. Reynolds CF III, Degenholtz H, Parker LS, Schulberg HC, Mulsant BH, Post E, Rollman B. Treatment as usual (TAU) control practices in the PROSPECT study: managing the interaction and tension between research design and ethics. Int J Geriatr Psychiatry 2001;16:602-8. (Pubitemid 32618853)
31. De Bruin M, Viechtbauer W, Hospers HJ, Schaalma HP, Kok G. Standard care quality determines treatment outcomes in control groups of HAART-adherence intervention studies: implications for the interpretation and comparison of intervention effects. Health Psychol 2009;28: 668-74.
32. De Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers HJ. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: a meta-analysis of randomized controlled trials. Arch Intern Med 2010;170:240-50.
33. Gava I, Barbui C, Aguglia E, Carlino D, Churchill R, De Vanna M, McGuire HF. Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev 2007;2:CD005333.
34. Staines GL, McKendrick K, Perlis T, Sacks S, De Leon G. Sequential assignment and treatment-as-usual. Alternatives to standard experimental designs in field studies of treatment efficacy. Eval Rev 1999;23:47-76.
35. Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, Albanese G, Kronish I, Hegel M, Burg MM. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med 2010;170:600-8.
36. Rollman BL, Belnap BH, LeMenager MS, Mazumdar S, Houck PR, Counihan PJ, Kapoor WN, Schulberg HC, Reynolds CF III. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA 2009;302:2095-103.
37. Alexopoulos GS, Reynolds CF III, Bruce ML, Katz IR, Raue PJ, Mulsant BH, Oslin DW, Ten HT. Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. Am J Psychiatry 2009;166:882-90.
38. Grossman P, Kappos L, Gensicke H, D'Souza M, Mohr DC, Penner IK, Steiner C. MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology 2010;75:1141-9.
39. Barratt R, Frost G, Millward DJ, Truby H. A randomised controlled trial investigating the effect of an intensive lifestyle intervention v. standard care in adults with type 2 diabetes immediately after initiating insulin therapy. Br J Nutr 2008;99:1025-31.
40. Byrne NM, Meerkin JD, Laukkanen R, Ross R, Fogelholm M, Hills AP. Weight loss strategies for obese adults: personalized weight management program vs. standard care. Obesity (Silver Spring) 2006;14:1777-88. (Pubitemid 46214801)
41. Raskin J, Smith TR, Wong K, Pritchett YL, D'Souza DN, Iyengar S, Wernicke JF. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. J Palliat Med 2006;9:29-40. (Pubitemid 43201767)
42. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Kerstens PJ, Nielen MM, Vos K, van Schaardenburg D, Speyer I, Seys PE, Breedveld FC, Allaart CF, Dijkmans BA. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis. Ann Rheum Dis 2010;69: 65-9.
43. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N. Effects of treating depression and low perceived social support on clinical events after myo-cardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 2003;289:3106-16. (Pubitemid 37432886)
44. Bhardwaj A, Rehman SU, Mohammed A, Baggish AL, Moore SA, Januzzi JL Jr. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Am Heart J 2010;159:532-8.
45. Spiegel DA, Bruce TJ. Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials. Am J Psychiatry 1997;154:773-81. (Pubitemid 27230099)
46. Watanabe N, Churchill R, Furukawa TA. Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database Syst Rev 2009; 1:CD005335.
47. Eagle KA, Montoye CK, Riba AL, DeFranco AC, Parrish R, Skorcz S, Baker PL, Faul J, Jani SM, Chen B, Roychoudhury C, Elma MA, Mitchell KR, Mehta RH. Guideline-based standardized care is associated with substantially lower mortality in medicare patients with acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) Projects in Michigan. J Am Coll Cardiol 2005;46:1242-8. (Pubitemid 41615544)
48. Brignole M, Ungar A, Bartoletti A, Ponassi I, Lagi A, Mussi C, Ribani MA, Tava G, Disertori M, Quartieri F, Alboni P, Raviele A, Ammirati F, Scivales A, De Santo T. Standardized-care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals. Europace 2006;8:644-50. (Pubitemid 44295763)
49. Sofaer N, Eyal N. The diverse ethics of translational research. Am J Bioeth 2010;10:19-30.
50. Pace C, Miller FG, Danis M. Enrolling the uninsured in clinical trials: an ethical perspective. Crit Care Med 2003;31(suppl 3):S121-5. (Pubitemid 36379555)
51. Davis RM, Hitch AD, Salaam MM, Herman WH, Zimmer-Galler IE, Mayer-Davis EJ. TeleHealth improves diabetes self-management in an un-derserved community: diabetes TeleCare. Diabetes Care 2010;33:1712-7.
52. Haskell WL, Berra K, Arias E, Christopherson D, Clark A, George J, Hyde S, Klieman L, Myll J. Multifactor cardiovascular disease risk reduction in medically underserved, high-risk patients. Am J Cardiol 2006; 98:1472-9. (Pubitemid 44779477)
53. Goodman SG, Menon V, Cannon CP, Steg G, Ohman EM, Harrington RA. Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008;133(suppl 6):708S-75S. (Pubitemid 351892976)
54. Verheugt FW. Acute myocardial infarction associated with ST segment elevation and the new European Society of Cardiology guidelines. Heart 2009;95:1112-7.
55. Kushner FG, Hand M, Smith SC Jr, King SB III, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE Jr, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009;120:2271-306.
56. Crowe E, Lovibond K, Gray H, Henderson R, Krause T, Camm J. Early management of unstable angina and non-ST segment elevation myocar-dial infarction: summary of NICE guidance. BMJ 2010;340:c1134.
57. Kerr EA, Fleming B. Making performance indicators work: experiences of US Veterans Health Administration. BMJ 2007;335:971-3. (Pubitemid 350144664)
58. Tu JV, Khalid L, Donovan LR, Ko DT. Indicators of quality of care for patients with acute myocardial infarction. CMAJ 2008;179:909-15.
59. Lewis MH, Gohagan JK, Merenstein DJ. The locality rule and the physician's dilemma: local medical practices vs the national standard of care. JAMA 2007;297:2633-7. (Pubitemid 46961035)
60. Merenstein D. A piece of my mind. Winners and losers. JAMA 2004;291: 15-6.
61. Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 1997;337:853-6. (Pubitemid 27391640)
62. Varmus H, Satcher D. Ethical complexities of conducting research in developing countries. N Engl J Med 1997;337:1003-5. (Pubitemid 27425960)
63. Kent DM, Mwamburi DM, Bennish ML, Kupelnick B, Ioannidis JP. Clinical trials in sub-Saharan Africa and established standards of care: a systematic review of HIV, tuberculosis, and malaria trials. JAMA 2004;292:237-42. (Pubitemid 38918001)
64. Cohen MG, Fonarow GC, Peterson ED, Moscucci M, DaiD, Hernandez AF, Bonow RO, Smith SC Jr. Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation 2010;121:2294-301.
65. Werner RM, Goldman LE, Dudley RA. Comparison of change in quality of care between safety-net and nonYsafety-net hospitals. JAMA 2008;299: 2180-7. (Pubitemid 351679709)
66. Colon-Otero G, Smallridge RC, Solberg LA Jr, Keith TD, Woodward TA, Willis FB, Dunn AN. Disparities in participation in cancer clinical trials in the United States: a symptom of a healthcare system in crisis. Cancer 2008;112:447-54. (Pubitemid 351186183)
67. Gross CP. Racial disparities in clinical trial enrolment. Lancet 2008; 372:1713-4.
68. Timmermans S, McKay T. Clinical trials as treatment option: bioethics and health care disparities in substance dependency. Soc Sci Med 2009; 69:1784-90.
69. Byrne MM, Thompson P. Collective equipoise, disappointment, and the therapeutic misconception: on the consequences of selection for clinical research. Med Decis Making 2006;26:467-79. (Pubitemid 44410297)
70. Holroyd KA, Powers SW, Andrasik F. Methodological issues in clinical trials of drug and behavior therapies. Headache 2005;45:487-92. (Pubitemid 40847171)
71. Sheps SB. Research methods for surgeons: an overview. J Invest Surg 1993;6:321-8. (Pubitemid 23256559)
72. Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw A, Bortey E, Forbes WP. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010;362:1071-81.
73. Donta ST, Clauw DJ, Engel CC Jr, Guarino P, Peduzzi P, Williams DA, Skinner JS, Barkhuizen A, Taylor T, Kazis LE, Sogg S, Hunt SC, Dougherty CM, Richardson RD, Kunkel C, Rodriguez W, Alicea E, Chiliade P, Ryan M, Gray GC, Lutwick L, Norwood D, Smith S, Everson M, Blackburn W, Martin W, Griffiss JM, Cooper R, Renner E, Schmitt J, McMurtry C, Thakore M, Mori D, Kerns R, Park M, Pullman-Mooar S, Bernstein J, Hershberger P, Salisbury DC, Feussner JR. Cognitive behavioral therapy and aerobic exercise for Gulf War veterans' illnesses: a randomized controlled trial. JAMA 2003;289:1396-404. (Pubitemid 37430307)
74. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309. (Pubitemid 351665487)
75. Powell LH, Calvin JE Jr, Richardson D, Janssen I, Mendes de Leon CF, Flynn KJ, Grady KL, Rucker-Whitaker CS, Eaton C, Avery E. Self-management counseling in patients with heart failure: the heart failure adherence and retention randomized behavioral trial. JAMA 2010;304: 1331-8.
76. Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, Patkar A, Publicker M, McCain K, Potter JS, Forman R, Vetter V, McNicholas L, Blaine J, Lynch KG, Fudala P. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA 2008;300:2003-11.
77. Thiels C, Schmidt U, Treasure J, Garthe R, Troop N. Guided self-change for bulimia nervosa incorporating use of a self-care manual. Am J Psychiatry 1998;155:947-53. (Pubitemid 28307608)
78. Carroll KM, Connors GJ, Cooney NL, DiClemente CC, Donovan DM, Kadden RR, Longabaugh RL, Rounsaville BJ, Wirtz PW, Zweben A. Internal validity of Project MATCH treatments: discriminability and integrity. J Consult Clin Psychol 1998;66:290-303. (Pubitemid 28208311)
79. Allen LA, Woolfolk RL, Escobar JI, Gara MA, Hamer RM. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med 2006;166:1512-8. (Pubitemid 44125871)
80. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med 2001;135:825-34. (Pubitemid 33051266)
81. Safford MM, Shewchuk R, Qu H, Williams JH, Estrada CA, Ovalle F, Allison JJ. Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care. J Gen Intern Med 2007;22: 1648-55. (Pubitemid 350160352)
82. Henke RM, Zaslavsky AM, McGuire TG, Ayanian JZ, Rubenstein LV. Clinical inertia in depression treatment. Med Care 2009;47:959-67.
83. Katon W, Russo J, Lin EH, Heckbert SR, Karter AJ, Williams LH, Ciechanowski P, Ludman E, Von KM. Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med 2009;71:965-72.
84. Rose AJ, Berlowitz DR, Manze M, Orner MB, Kressin NR. Comparing methods of measuring treatment intensification in hypertension care. Circ Cardiovasc Qual Outcomes 2009;2:385-91.
85. Katon WJ, Von KM, Lin EH, Simon G, Ludman E,RussoJ,Ciechanowski P, Walker E, Bush T. The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004; 61:1042-9. (Pubitemid 39336538)
86. Fraker TD Jr, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Williams SV, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. Circulation 2007; 116:2762-72. (Pubitemid 350291248)
87. Kowalski CJ. Pragmatic problems with clinical equipoise. Perspect Biol Med 2010;53:161-73.
88. Miller FG, Brody H. What makes placebo-controlled trials unethical? Am J Bioeth 2002;2:3-9.
89. Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, Stedman SW, Young DR. Effects of comprehensive lifestyle modification on blood pressure control: main results of the Premier clinical trial. JAMA 2003;289: 2083-93. (Pubitemid 37430210)
90. Svetkey LP, Harsha DW, Vollmer WM, Stevens VJ, Obarzanek E, Elmer PJ, Lin PH, Champagne C, Simons-Morton DG, Aickin M, Proschan MA, Appel LJ. Premier: a clinical trial of comprehensive lifestyle modification for blood pressure control: rationale, design and baseline characteristics. Ann Epidemiol 2003;13:462-71. (Pubitemid 36870816)
91. Snapinn SM. Noninferiority trials. Curr Control Trials Cardiovasc Med 2000;1:19-21. (Pubitemid 32219869)
92. Califf RM. A perspective on the regulation of the evaluation of new antithrombotic drugs. Am J Cardiol 1998;82:25P-35P. (Pubitemid 28511779)
93. Mohr DC, Vella L, Hart S, Heckman T, Simon G. The effect of telephone-administered psychotherapy on symptoms of depression and attrition: a meta-analysis. Clin Psychol (New York) 2008;15:243-53.
94. Mohr DC, Siddique J, Ho J, Duffecy J, Jin L, Fokuo JK. Interest in behavioral and psychological treatments delivered face-to-face, by telephone, and by internet. Ann Behav Med 2010;40:89-98.
95. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-5. (Pubitemid 17092151)
96. Miller FG, Brody H. A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Hastings Cent Rep 2003;33: 19-28.
97. Miller FG, Brody H. Clinical equipoise and the incoherence of research ethics. J Med Philos 2007;32:151-65. (Pubitemid 46598162)
98. Killaspy H, Kingett S, Bebbington P, Blizard R, Johnson S, Nolan F, Pilling S, King M. Randomised evaluation of assertive community treatment: 3-year outcomes. Br J Psychiatry 2009;195:81-2.
99. Jensen PS, Weersing R, Hoagwood KE, Goldman E. What is the evidence for evidence-based treatments? A hard look at our soft underbelly. Ment Health Serv Res 2005;7:53-74. (Pubitemid 40372354)
100. Eisenberg DM, Delbanco TL, Berkey CS, Kaptchuk TJ, Kupelnick B, Kuhl J, Chalmers TC. Cognitive behavioral techniques for hypertension: are they effective? Ann Intern Med 1993;118:964-72. (Pubitemid 23164135)
101. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002;287: 1840-7. (Pubitemid 34303629)
102. Fawcett J, Epstein P, Fiester SJ, Elkin I, Autry JH. Clinical managementV imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program. Psychopharmacol Bull 1987;23: 309-24.
103. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, Mclvor M. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-9. (Pubitemid 34848222)
104. Brent DA, Holder D, Kolko D, Birmaher B, Baugher M, Roth C, Iyengar S, Johnson BA. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry 1997;54:877-85. (Pubitemid 27383316)
105. Edinger JD, Wohlgemuth WK, Radtke RA, Coffman CJ, Carney CE. Dose-response effects of cognitive-behavioral insomnia therapy: a randomized clinical trial. Sleep 2007;30:203-12.
106. Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M, Otto MW. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 2010;304:875-80.
107. Wampold BE. The great psychotherapy debate: models, methods, and findings. Mahwah, NJ: L. Erlbaum Associates; 2001.
108. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O'Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005;62:409-16. (Pubitemid 40471690)
109. Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP, Lovett ML, Young PR, Haman KL, Freeman BB, Gallop R. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 2005;62:417-22. (Pubitemid 40471691)
110. Klein DF. Preventing hung juries about therapy studies. J Consult Clin Psychol 1996;64:81-7. (Pubitemid 26076068)
111. Cochran BN, Pruitt L, Fukuda S, Zoellner LA, Feeny NC. Reasons underlying treatment preference: an exploratory study. J Interpers Violence 2008;23:276-91.
112. King M, Nazareth I, Lampe F, Bower P, Chandler M, Morou M, Sibbald B, Lai R. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials. Health Technol Assess 2005;9:1-186.
113. Robinson EJ, Kerr CE, Stevens AJ, Lilford RJ, Braunholtz DA, Edwards SJ, Beck SR, Rowley MG. Lay public's understanding of equipoise and randomisation in randomised controlled trials. Health Technol Assess 2005;9:1-192.
114. Bedi N, Chilvers C, Churchill R, Dewey M, Duggan C, Fielding K, Gretton V, Miller P, Harrison G, Lee A, Williams I. Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry 2000;177:312-8.
115. Adamson SJ, Sellman DJ, Dore GM. Therapy preference and treatment outcome in clients with mild to moderate alcohol dependence. Drug Alcohol Rev 2005;24:209-16. (Pubitemid 41451931)
116. Hegerl U, Hautzinger M, Mergl R, Kohnen R, Schutze M, Scheunemann W, Allgaier AK, Coyne J, Henkel V. Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, con-trolled trial including a patients' choice arm. Int J Neuropsychopharmacol 2010;13:31-44.
117. King M, Nazareth I, Lampe F, Bower P, Chandler M, Morou M, Sibbald B, Lai R. Impact of participant and physician intervention preferences on randomized trials: a systematic review. JAMA 2005;293:1089-99. (Pubitemid 40300283)
118. Chilvers C, Dewey M, Fielding K, Gretton V, Miller P, Palmer B, Weller D, Churchill R, Williams I, Bedi N, Duggan C, Lee A, Harrison G. Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ 2001;322:772-5. (Pubitemid 32269653)
119. Preference Collaborative Review Group. Patients' preferences within randomised trials: systematic review and patient level meta-analysis. BMJ 2008;337:a1864.
120. Kocsis JH, Leon AC, Markowitz JC, Manber R, Arnow B, Klein DN, Thase ME. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. J Clin Psychiatry 2009;70:354-61.
121. Kwan BM, Dimidjian S, Rizvi SL. Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression. Behav Res Ther 2010;48:799-804.
122. Lin P, Campbell DG, Chaney EF, Liu CF, Heagerty P, Felker BL, Hedrick SC. The influence of patient preference on depression treatment in primary care. Ann Behav Med 2005;30:164-73. (Pubitemid 41377194)
123. Colagiuri B. Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity. Clin Trials 2010;7: 246-55.
124. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001; 344:1594-602. (Pubitemid 32479913)
125. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med 2004;256:91-100. (Pubitemid 38998255)
126. Hrobjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010;1:CD003974.
127. Olshansky B. Placebo and nocebo in cardiovascular health: implications for healthcare, research, and the doctor-patient relationship. J Am Coll Cardiol 2007;49:415-21. (Pubitemid 46135884)
128. Kaptchuk TJ, Friedlander E, Kelley JM, Sanches MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS ONE 2010;5:e15591.
129. Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol 2009;19: 34-40.
130. Rutherford B, Sneed J, Devanand D, Eisenstadt R, Roose S. Antide-pressant study design affects patient expectancy: a pilot study. Psychol Med 2010;40:781-8.
131. Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctot KL. Does inclusion of a placebo arm influence response to active anti-depressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J Clin Psychiatry 2010;71:270-9.
132. Stone DA, Kerr CE, Jacobson E, Conboy LA, Kaptchuk TJ. Patient expectations in placebo-controlled randomized clinical trials. J Eval Clin Pract 2005;11:77-84. (Pubitemid 40204144)
133. Colagiuri B, Morley K, Boakes R, Haber P. Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence. Psy-chother Psychosom 2009;78:167-71.
134. Davidson KW, Trudeau KJ, Ockene JK, Orleans CT, Kaplan RM. A primer on current evidence-based review systems and their implications for behavioral medicine. Ann Behav Med 2004;28:226-38. (Pubitemid 39578436)